Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Pfizer responds to claims linking Viagra to NAION

June 1, 2005

New agents claimed for the treatment of diabetes

June 1, 2005

Organon obtains license for Merck's novel oral contraceptive

June 1, 2005

Additional data on efficacy of exenatide in patients with type 2 diabetes

May 31, 2005

Zemplar capsules receive FDA approval

May 31, 2005

SCLOR Pharma evaluates bioavailability of CDT-raloxifene

May 30, 2005

New data on the benefits of lasofoxifene in vaginal atrophy

May 30, 2005

Extended use of the contraceptive NuvaRing reported safe and effective

May 30, 2005

Xenical receives positive opinion in E.U. for weight loss in adolescents

May 27, 2005

Muraglitazar effective in randomized, double-blind trials in type 2 diabetes

May 27, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...